CHINA CHENGTONG (00217) signed agreements with Power Construction Corporation of China, Ltd (POWERCHINA) in Wuhan and Zhengzhou.
China Chengtong Development Group (00217) announces that on October 27, 2025, the company's indirect wholly-owned subsidiary ...
CHINA CHENGTONG (00217) announced that on October 27, 2025, the company's indirectly wholly-owned subsidiary Chengtong Finance Lease entered into agreements with Power Construction Corporation of China, Ltd (POWERCHINA Real Estate and Wuhan Longyue Joint Lessees) and Power Construction Corporation of China, Ltd (POWERCHINA Real Estate and Zhengzhou Yuechen Joint Lessees. Chengtong Finance Lease agreed to purchase lease assets from the joint lessees and then lease them back to them for a period of 2 years, with the option to terminate early as per the terms of the agreements.
In accordance with the arrangement with Power Construction Corporation of China, Ltd (POWERCHINA Real Estate and Wuhan Longyue), Chengtong Finance Lease agreed to pay a total purchase price of 200 million yuan for the lease assets, based on the reference value of the assets of approximately 215 million yuan as of September 30, 2025.
Similarly, in accordance with the arrangement with Power Construction Corporation of China, Ltd (POWERCHINA Real Estate and Zhengzhou Yuechen), Chengtong Finance Lease agreed to pay a total purchase price of 300 million yuan for the lease assets, based on the reference value of the assets of approximately 307 million yuan as of September 30, 2025.
The arrangements with Power Construction Corporation of China, Ltd (POWERCHINA Real Estate and Wuhan Longyue) and Power Construction Corporation of China, Ltd (POWERCHINA Real Estate and Zhengzhou Yuechen) were made in the course of Chengtong Finance Lease's general and day-to-day business operations, with expected revenues of approximately 12.9 million yuan and 19.34 million yuan respectively to be earned under these arrangements, comprising service fees and lease interest payments.
Related Articles

US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.

US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.

The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


